Allison Barz Leahy

Statistics

Publications

Citations

4.4K

H-Index

Active since

2001

Affiliations

Children's Hospital of Philadelphia(Current)

University of Pennsylvania

Parker Institute for Cancer Immunotherapy

Memorial Sloan Kettering Cancer Center

University of North Carolina at Chapel Hill

Allison Barz Leahy is an author at Children's Hospital of Philadelphia specializing in oncology, medicine, and chimeric antigen receptor t-cell therapy.

ORCID

Publications per year

2001–2025

Publications

Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial

Ethan Basch, Allison M. Deal, Mark G. Kris et al. · Journal of Clinical Oncology · 2015 · 2.7K citations · Full text

Pharmacy, Health Informatics, Oncology +17

Risk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome After CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical Trial

Stephan Kadauke, Regina M. Myers, Yimei Li et al. · Journal of Clinical Oncology · 2021 · 212 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Long-Term Toxicity Monitoring via Electronic Patient-Reported Outcomes in Patients Receiving Chemotherapy

Ethan Basch, Alexia Iasonos, Allison Barz Leahy et al. · Journal of Clinical Oncology · 2007 · 209 citations

Nursing, Health Informatics, Oncology Nursing +16

Humanized CD19-Targeted Chimeric Antigen Receptor (CAR) T Cells in CAR-Naive and CAR-Exposed Children and Young Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia

Regina M. Myers, Yimei Li, Allison Barz Leahy et al. · Journal of Clinical Oncology · 2021 · 187 citations · Full text

Medicine, Hematology, Oncology +16

Feasibility of Long-Term Patient Self-Reporting of Toxicities From Home via the Internet During Routine Chemotherapy

Timothy J. Judson, Antonia V. Bennett, Lauren J. Rogak et al. · Journal of Clinical Oncology · 2013 · 161 citations · Full text

Pharmacy, Oncology, Chemotherapy +15

1–5 of 28